TABLE 3.
Patient | 1 yr | 2 yr | 3 yr | 5 yr |
---|---|---|---|---|
Males | ||||
NSCLC | 87 | 57 | 48 | 14 |
NSCLC adenocarcinoma | 95 | 71 | 47 | 16 |
NSCLC squamous cell | 83 | 56 | 56 | 19 |
NSCLC with brain metastasis | 89 | 78 | 52 | No dataa |
SCLC | 57 | 25 | 17 | 17 |
All subtypes | 77 | 51 | 38 | 19 |
Females | ||||
NSCLC | 92 | 72 | 58 | 53 |
NSCLC adenocarcinoma | 97 | 81 | 66 | 59 |
NSCLC squamous cell | 75 | 62 | 47 | 47 |
NSCLC with brain metastasis | 89 | 63 | 32 | 32 |
SCLC | 100 | 75 | 75 | 50 |
All subtypes | 94 | 75 | 60 | 52 |
Males and females | ||||
NSCLC | 89 | 63 | 53 | 35 |
NSCLC adenocarcinoma | 96 | 77 | 59 | 44 |
NSCLC squamous cell | 83 | 60 | 55 | 31 |
NSCLC with brain metastasis | 89 | 69 | 41 | 41 |
SCLC | 69 | 40 | 33 | 25 |
All subtypes | 84 | 60 | 47 | 33 |
NSCLC = nonsmall cell lung carcinoma; SCLC = small cell lung carcinoma.
There were no patients under observation in this group at 5 yr.